CD43 Primary Antibody

Item Information
Catalog #
Size
Price
Description

This gene encodes a highly sialylated glycoprotein that functions in antigen-specific activation of T cells, and is found on the surface of thymocytes, T lymphocytes, monocytes, granulocytes, and some B lymphocytes. It contains a mucin-like extracellular domain, a transmembrane region and a carboxy-terminal intracellular region. The extracellular domain has a high proportion of serine and threonine residues, allowing extensive O-glycosylation, and has one potential N-glycosylation site, while the carboxy-terminal region has potential phosphorylation sites that may mediate transduction of activation signals. Different glycoforms of this protein have been described. In stimulated immune cells, proteolytic cleavage of the extracellular domain occurs in some cell types, releasing a soluble extracellular fragment. Defects in expression of this gene are associated with Wiskott-Aldrich syndrome.

Product Overview
Entrez GenelD
6693
Aliases
LSN; SPN; GALGP; GPL115
Clone#
3E12F3
Host / Isotype
Mouse / Mouse IgG1
Immunogen
Purified recombinant fragment of human CD43(AA: extra(20-169)) expressed in E. Coli.
Formulation
Purified antibody in PBS with 0.05% sodium azide
Storage
4°C; -20°C for long term storage
Product Applications
WB (Western Blot)
1/500 - 1/2000
IHC_P(Immunohistochemistry)
1/200-1/1000
FCM (Flow Cytometry)
1/200-1/400
ELISA
1/10000
References
1,Ann Diagn Pathol.2017 Aug;29:23-27;2,Cytometry B Clin Cytom. 2018 Jan;94(1):136-142.
Product Image
ELISA
Figure 1: Black line: Control Antigen (100 ng);Purple line: Antigen (10ng); Blue line: Antigen (50 ng); Red line: Antigen (100 ng)
Figure 1: Black line: Control Antigen (100 ng);Purple line: Antigen (10ng); Blue line: Antigen (50 ng); Red line: Antigen (100 ng)
WESTERN BLOT
Figure 2: Western blot analysis using CD43 mAb against human CD43(AA: extra(20-169)) recombinant protein. (Expected MW is 33.3kDa)
Figure 2: Western blot analysis using CD43 mAb against human CD43(AA: extra(20-169)) recombinant protein. (Expected MW is 33.3kDa)
WESTERN BLOT
Figure 3: Western blot analysis using CD43 mouse mAb against HEK293-6E (1), HEK293 (2),K562 (3), MOLT4 (4), Jurkat (5),and PANC-1 (6) cell lysate.
Figure 3: Western blot analysis using CD43 mouse mAb against HEK293-6E (1), HEK293 (2),K562 (3), MOLT4 (4), Jurkat (5),and PANC-1 (6) cell lysate.
FLOW CYTOMETRY
Figure 4: Flow cytometric analysis of Jurkat cells using CD43 mouse mAb (green) and negative control (red).
Figure 4: Flow cytometric analysis of Jurkat cells using CD43 mouse mAb (green) and negative control (red).
IMMUNOHISTOCHEMISTRY
Figure 5: Immunohistochemical analysis of paraffin-embedded bladder cancer tissues using CD43 mouse mAb with DAB staining.
Figure 5: Immunohistochemical analysis of paraffin-embedded bladder cancer tissues using CD43 mouse mAb with DAB staining.
WESTERN BLOT
Figure 6: Western blot analysis using CD43 mAb against HEK293-6E (1) and CD43(AA: extra(20-169))-hIgGFc transfected HEK293-6E (2) cell lysate.
Figure 6: Western blot analysis using CD43 mAb against HEK293-6E (1) and CD43(AA: extra(20-169))-hIgGFc transfected HEK293-6E (2) cell lysate.
For Research Use Only. Not for use in diagnostic procedures.